Urinary kidney injury molecule-1 and the risk of cardiovascular mortality in elderly men

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 8, 2014, Pages 1393-1401

  Carlsson, Axel C ^a,b   Larsson, Anders ^c   Helmersson Karlqvist, Johanna ^c   Lind, Lars ^c   Ingelsson, Erik ^b   Larsson, Tobias E ^a   Bottai, Matteo ^a   Sundström, Johan ^b   ÄrnlÖv, Johan ^b,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d DALARNA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ANTILIPEMIC AGENT; CREATININE; CYSTATIN C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KIDNEY INJURY MOLECULE 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; BIOLOGICAL MARKER; CREATINE; HAVCR1 PROTEIN, HUMAN; MEMBRANE PROTEIN; VIRUS RECEPTOR;

AGE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BIOCHEMISTRY; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; KIDNEY DYSFUNCTION; KIDNEY INJURY; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MICROALBUMINURIA; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; SMOKING; SYSTOLIC BLOOD PRESSURE; URINALYSIS; ALBUMINURIA; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; KIDNEY; KIDNEY DISEASES; LONGITUDINAL STUDY; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX DIFFERENCE; SWEDEN; TIME; UPREGULATION; URINE;

AGE FACTORS; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CREATINE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY; KIDNEY DISEASES; LONGITUDINAL STUDIES; MALE; MEMBRANE GLYCOPROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECEPTORS, VIRUS; RISK FACTORS; SEX FACTORS; SWEDEN; TIME FACTORS; UP-REGULATION;

EID: 84923781858     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.11901113     Document Type: Article

References (44)

1. Arnlöv J: Diminished renal function and the incidence of heart failure. Curr Cardiol Rev 5: 223–227, 2009.
2. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative metaanalysis. Lancet 375: 2073–2081, 2010.
3. Nerpin E, Ingelsson E, Risérus U, Sundström J, Larsson A, Jobs E, Jobs M, Hallan S, Zethelius B, Berglund L, Basu S, Arnlöv J: The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascularmortality in elderly men. Nephrol Dial Transplant 26: 2820–2827, 2011.
4. Humphreys BD, Xu F, Sabbisetti V, Grgic I, Naini SM, Wang N, Chen G, Xiao S, Patel D, Henderson JM, Ichimura T, Mou S, Soeung S, McMahon AP, Kuchroo VK, Bonventre JV: Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. J Clin Invest 123: 4023–4035, 2013.
5. Huo W, Zhang K, Nie Z, Li Q, Jin F: Kidney injury molecule-1 (KIM-1): A novel kidney-specific injury molecule playing potential double-edged functions in kidney injury. Transplant Rev (Orlando) 24: 143–146, 2010.
6. Waanders F, van Timmeren MM, Stegeman CA, Bakker SJ, van Goor H: Kidney injury molecule-1 in renal disease. J Pathol 220: 7–16, 2010.
7. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV: Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int 62: 237–244, 2002.
8. Ko GJ, Grigoryev DN, Linfert D, Jang HR, Watkins T, Cheadle C, Racusen L, Rabb H: Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition. Am J Physiol Renal Physiol 298: F1472–F1483, 2010.
9. Peralta CA, Katz R, Bonventre JV, Sabbisetti V, Siscovick D, Sarnak M, Shlipak MG: Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi- Ethnic Study of Atherosclerosis (MESA). AmJ KidneyDis 60: 904–911, 2012.
10. Rees AJ, Kain R: Kim-1/Tim-1: From biomarker to therapeutic target? Nephrol Dial Transplant 23: 3394–3396, 2008.
11. Vaidya VS, Ferguson MA, Bonventre JV: Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol 48: 463–493, 2008.
12. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA: Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 212: 209–217, 2007.
13. van Timmeren MM, Vaidya VS, van Ree RM, Oterdoom LH, de Vries AP, Gans RO, van Goor H, Stegeman CA, Bonventre JV, Bakker SJ: High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplantation 84: 1625–1630, 2007.
14. Liangos O, Perianayagam MC, Vaidya VS, Han WK, Wald R, Tighiouart H, MacKinnon RW, Li L, Balakrishnan VS, Pereira BJ, Bonventre JV, Jaber BL: UrinaryN-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol 18: 904–912, 2007.
15. Damman K, Masson S, Hillege HL, Maggioni AP, Voors AA, Opasich C, van Veldhuisen DJ, Montagna L, Cosmi F, Tognoni G, Tavazzi L, Latini R: Clinical outcome of renal tubular damage in chronic heart failure. Eur Heart J 32: 2705–2712, 2011.
16. Byberg L, Zethelius B, McKeigue PM, Lithell HO: Changes in physical activity are associated with changes in metabolic cardiovascular risk factors. Diabetologia 44: 2134–2139, 2001.
17. Hagström E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundström J, Melhus H, Held C, Lind L, Michaëlsson K, Arnlöv J: Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119: 2765–2771, 2009.
18. Carlsson AC, Calamia M, Risérus U, Larsson A, Helmersson- Karlqvist J, Lind L, Arnlöv J: Kidney injury molecule (KIM)-1 is associated with insulin resistance: Results from two communitybased studies of elderly individuals. Diabetes Res Clin Pract 103: 516–521, 2014.
19. Carlsson AC, Larsson A, Helmersson-Karlqvist J, Lind L, Ingelsson E, Larsson TE, Sundström J, Arnlöv J: Urinary kidney injury molecule 1 and incidence of heart failure in elderly men. Eur J Heart Fail 15: 441–446, 2013.
20. Larsson A, Malm J, Grubb A, Hansson LO: Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest 64: 25–30, 2004.
21. Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J AmStat Assoc 94: 496–509, 1999.
22. Lin DY: Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 16: 901–910, 1997.
23. Cepeda MS, Boston R, Farrar JT, Strom BL: Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol 158: 280–287, 2003.
24. Wändell P, Carlsson AC, Sundquist J, Johansson SE, Bottai M, Sundquist K: Effects of prescribed antithrombotics and other cardiovascular pharmacotherapies on all-cause mortality in patients with diabetes and atrial fibrillation - a cohort study from Sweden using propensity score analyses. Diabetol Metab Syndr 6: 2, 2014.
25. Daniels LB, Barrett-Connor E, Clopton P, Laughlin GA, Ix JH, Maisel AS: Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study. J Am Coll Cardiol 59: 1101–1109, 2012.
26. Nauta FL, Bakker SJ, van Oeveren W, Navis G, van der Heide JJ, van Goor H, de Jong PE, Gansevoort RT: Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients. Am J Kidney Dis 57: 733–743, 2011.
27. Sarnak MJ, Katz R, Newman A, Harris T, Peralta CA, Devarajan P, Bennett MR, Fried L, Ix JH, Satterfield S, Simonsick EM, Parikh CR, Shlipak MG; for the Health ABC Study: Association of urinary injury biomarkers with mortality and cardiovascular events [published online ahead of print February 7, 2014]. J Am Soc Nephrol doi:10.1681/ASN.2013070713.
28. O’Seaghdha CM, Hwang SJ, Larson MG, Meigs JB, Vasan RS, Fox CS: Analysis of a urinary biomarker panel for incident kidney disease and clinical outcomes. J Am Soc Nephrol 24: 1880–1888, 2013.
29. Helmersson-Karlqvist J, Larsson A, Carlsson AC, Venge P, Sundström J, Ingelsson E, Lind L, Arnlöv J: Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with mortality in a community-based cohort of older Swedish men. Atherosclerosis 227: 408–413, 2013.
30. Vaidya VS, Niewczas MA, Ficociello LH, Johnson AC, Collings FB, Warram JH, Krolewski AS, Bonventre JV: Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-b-D-glucosaminidase. Kidney Int 79: 464–470, 2011.
31. Thurman JM: Triggers of inflammation after renal ischemia/ reperfusion. Clin Immunol 123: 7–13, 2007.
32. Schupp N, Kolkhof P, Queisser N, Gärtner S, Schmid U, Kretschmer A, Hartmann E, Oli RG, Schäfer S, Stopper H: Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats. FASEB J 25: 968–978, 2011.
33. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW: Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 290: 891–897, 2003.
34. Damman K, Van Veldhuisen DJ, Navis G, Vaidya VS, Smilde TD, Westenbrink BD, Bonventre JV, Voors AA, Hillege HL: Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate. Heart 96: 1297–1302, 2010.
35. Jungbauer CG, Birner C, Jung B, Buchner S, Lubnow M, von Bary C, Endemann D, Banas B, Mack M, Böger CA, Riegger G, Luchner A: Kidney injury molecule-1 and N-acetyl-b-Dglucosaminidase in chronic heart failure: Possible biomarkers of cardiorenal syndrome. Eur J Heart Fail 13: 1104–1110, 2011.
36. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, Sanicola M: Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273: 4135–4142, 1998.
37. Bonventre JV: Kidney injury molecule-1 (KIM-1): A urinary biomarker and much more. Nephrol Dial Transplant 24: 3265–3268, 2009.
38. Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, Krawczeski CD, Koyner JL, Murray P, Zappitelli M, Goldstein SL, Makris K, Ronco C, Martensson J, Martling CR, Venge P, Siew E, Ware LB, Ikizler TA, Mertens PR: The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: Amulticenter pooled analysis of prospective studies. J Am Coll Cardiol 57: 1752–1761, 2011.
39. Bonventre JV, Vaidya VS, Schmouder R, Feig P, Dieterle F: Nextgeneration biomarkers for detecting kidney toxicity. Nat Biotechnol 28: 436–440, 2010.
40. Damman K, Ng Kam Chuen MJ, MacFadyen RJ, Lip GY, Gaze D, Collinson PO, Hillege HL, van Oeveren W, Voors AA, van Veldhuisen DJ: Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function. J Am Coll Cardiol 57: 2233–2241, 2011.
41. Waanders F, Vaidya VS, van Goor H, Leuvenink H, Damman K, Hamming I, Bonventre JV, Vogt L, Navis G: Effect of reninangiotensin- aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: A post hoc analysis of a randomized controlled trial. Am J Kidney Dis 53: 16–25, 2009.
42. Almgren T, Wilhelmsen L, Samuelsson O, Himmelmann A, Rosengren A, Andersson OK: Diabetes in treated hypertension is common and carries a high cardiovascular risk: Results from a 28-year follow-up. J Hypertens 25: 1311–1317, 2007.
43. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO: External review and validation of the Swedish national inpatient register. BMC Public Health 11: 450, 2011.
44. Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT; CKD Prognosis Consortium: Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 369: 932–943, 2013.